About
Pertussis Vaccine
Areas of Focus
Categories
VaccineSoutheastern U.S.
Team (35)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
765
By Phase
PHASE2: 4
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05461131Lead Sponsor
Pertussis Challenge Study in Adults Vaccinated With BPZE1
PHASE2Completed
53 participants
Started: Jun 20, 2022 · Completed: Oct 26, 2023
NCT05116241Lead Sponsor
Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children
PHASE2Completed
367 participants
Started: Oct 28, 2021 · Completed: May 15, 2024
NCT03942406Lead Sponsor
Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults
PHASE2Completed
300 participants
Started: Jun 15, 2019 · Completed: Jun 24, 2020
NCT01252199Collaborator
Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2
PHASE2Completed
45 participants
Started: Nov 30, 2010 · Completed: Feb 28, 2013
Locations (1)
Headquarters
Weston, FL, United States
Map
Loading map...